Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Comment by whatdoiknow123on Aug 12, 2020 5:04pm
94 Views
Post# 31400288

RE:RE:RE:RE:RE:RE:Darn it, we have competition. :(

RE:RE:RE:RE:RE:RE:Darn it, we have competition. :(
TheeRook wrote: They firgured it out and its cheap to do.





How will SalivaDirect be offered?
A common question that we receive is “what company is behind this assay?” The answer is – well, there isn’t one. We designed and validated SalivaDirect using several common and already available reagents that any lab can immediately order. If one reagent is not available, there are alternative reagents to use (see table below). Thus, no new manufacturing is needed. We will continue to validate new reagents through bridging studies and will share that information here. A complete list of reagents and catalog numbers are listed in the protocol.
 


whatdoiknow123 wrote: NOT SO SIMPLE,

NOT SO SIMPLE,

saliva contains various enzymes that make the preparation for PCR tests more complicated, time consuming and costly. RNA  needs to be converted to DNA. Sensitivity is compromised. Probably will be overcome but not tomorrow. May cause similar problems with ANTIGEN TESTS  but I´m sure that theywill be working on it.

When all´s said and done a self-taken throat or buccal swab is not so difficult and not intrusive(much less so than a nasal swab),



1. Has it been passed yet for EUA .    NO
2. Do we have Sensitivity figures yet.   NO
3. Has any Saliva test yet been approved.   NO

At the moment it is a work in progress

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse